HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
NCT03906643
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Funding exhausted
Conditions
Solid Tumor
Interventions
DRUG:
HS-201
Sponsor
Herbert Lyerly